FASN and metabolic dysfunction-associated steatotic liver disease: Therefore, lipogenic enzymes, such as acetyl Co-A carboxylase (ACC) and fatty acid synthase (FASN) in the DNL pathway, are ideal targets for NAFLD treatment (Figure 1).